Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Gregory TK"" wg kryterium: Autor


Wyświetlanie 1-1 z 1
Tytuł:
Secondary solid cancer screening following hematopoietic cell transplantation.
Autorzy:
Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Shah NN; Pediatric Oncology Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institute of Health (NIH), Bethesda, MD, USA.
Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Shaw BE; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Abraham AA; Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, USA.
Ahmed IA; Department of Hematology Oncology and Bone Marrow Transplantation, The Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.
Akpek G; Section of Hematology Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
Atsuta Y; 1] Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan [2] Nagoya University Graduate School of Medicine, Nagoya, Japan.
Baker KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Basak GW; Department of Hematology, Oncology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland.
Bitan M; Department of Pediatric Hematology/Oncology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
DeFilipp Z; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
Gregory TK; Colorado Blood Cancer Institute at Presbyterian/St Luke's Medical Center, Denver, CO, USA.
Greinix HT; Bone Marrow Transplantation Unit, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
Hamadani M; Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Hamilton BK; Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Hayashi RJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St Louis, St Louis, MO, USA.
Jacobsohn DA; Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC, USA.
Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA.
Kasow KA; Division of Hematology-Oncology, Department of Pediatrics, University of North Carolina, Chapel Hill, NC, USA.
Khera N; Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA.
Lazarus HM; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
Malone AK; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Lupo-Stanghellini MT; Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Scientific Institute, Milano, Italy.
Margossian SP; Department of Pediatric Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.
Muffly LS; Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA.
Norkin M; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
Ramanathan M; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worchester, MA, USA.
Salooja N; Imperial College, London, UK.
Schoemans H; University Hospital of Leuven, Leuven, Belgium.
Wingard JR; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
Wirk B; Department of Internal Medicine, Stony Brook University Medical Center, Stony Brook, NY, USA.
Wood WA; Division of Hematology/Oncology, Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, NC, USA.
Yong A; Royal Adelaide Hospital/SA Pathology and School of Medicine, University of Adelaide, Adelaide, Australia.
Duncan CN; Department of Pediatric Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Boston, MA, USA.
Flowers ME; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Majhail NS; Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Pokaż więcej
Źródło:
Bone marrow transplantation [Bone Marrow Transplant] 2015 Aug; Vol. 50 (8), pp. 1013-23. Date of Electronic Publication: 2015 Mar 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.; Review
MeSH Terms:
Mass Screening*
Hematopoietic Stem Cell Transplantation/*adverse effects
Neoplasms, Second Primary/*diagnosis
Female ; Humans ; Male ; Neoplasms, Second Primary/epidemiology ; Organ Specificity ; Risk Factors
Czasopismo naukowe
    Wyświetlanie 1-1 z 1

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies